Tenax Therapeutics Stock Price on August 7, 2024
TENX Stock | USD 6.00 0.11 1.87% |
Below is the normalized historical share price chart for Tenax Therapeutics extending back to July 24, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tenax Therapeutics stands at 6.00, as last reported on the 7th of December, with the highest price reaching 6.09 and the lowest price hitting 5.76 during the day.
If you're considering investing in Tenax Stock, it is important to understand the factors that can impact its price. Tenax Therapeutics appears to be slightly risky, given 3 months investment horizon. Tenax Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.23, which indicates the firm had a 0.23% return per unit of risk over the last 3 months. By inspecting Tenax Therapeutics' technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please review Tenax Therapeutics' Semi Deviation of 2.54, risk adjusted performance of 0.1579, and Coefficient Of Variation of 493.77 to confirm if our risk estimates are consistent with your expectations.
At this time, Tenax Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 260.9 K in 2024, whereas Common Stock is likely to drop 28.50 in 2024. . At this time, Tenax Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 0.71 in 2024, whereas Price Earnings Ratio is likely to drop (0.74) in 2024. Tenax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of January 1997 | 200 Day MA 3.8572 | 50 Day MA 4.4259 | Beta 2.154 |
Tenax |
Sharpe Ratio = 0.234
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | TENX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.5 actual daily | 31 69% of assets are more volatile |
Expected Return
0.82 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
0.23 actual daily | 18 82% of assets perform better |
Based on monthly moving average Tenax Therapeutics is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tenax Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.2104 | Book Value 27.149 | Enterprise Value 11.3 M | Enterprise Value Ebitda (0.14) | Shares Float 2.6 M |
Related Headline
Ensysce Biosciences Headline on 7th of August 2024
ENSC stock touches 52-week low at 0.37 amid market challenge... by news.google.com
ENSC stock touches 52-week low at 0.37 amid market challenges Investing.com
Tenax Therapeutics Valuation on August 7, 2024
It is possible to determine the worth of Tenax Therapeutics on a given historical date. On August 7, 2024 Tenax was worth 3.73 at the beginning of the trading date compared to the closed value of 4.07. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tenax Therapeutics stock. Still, in general, we apply an absolute valuation method to find Tenax Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tenax Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tenax Therapeutics' related companies.
Open | High | Low | Close | Volume | |
4.93 | 5.15 | 3.54 | 3.76 | 28,053,150 | |
08/07/2024 | 3.73 | 4.49 | 3.65 | 4.07 | 1,350,452 |
3.98 | 4.38 | 3.84 | 4.14 | 391,289 |
Backtest Tenax Therapeutics | | | Tenax Therapeutics History | | | Tenax Therapeutics Valuation | Previous | Next |
Tenax Therapeutics Trading Date Momentum on August 7, 2024
On August 08 2024 Tenax Therapeutics was traded for 4.14 at the closing time. The top price for the day was 4.38 and the lowest listed price was 3.84 . The trading volume for the day was 391.3 K. The trading history from August 8, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 1.72% . The trading price change against the current closing price is 2.95% . |
Tenax Therapeutics Fundamentals Correlations and Trends
By evaluating Tenax Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tenax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tenax Therapeutics Stock history
Tenax Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tenax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tenax Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tenax Therapeutics stock prices may prove useful in developing a viable investing in Tenax Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 248.4 K | 260.9 K | |
Net Loss | -29.2 M | -27.8 M |
Tenax Therapeutics Quarterly Net Working Capital |
|
Tenax Therapeutics Stock Technical Analysis
Tenax Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tenax Therapeutics Period Price Range
Low | December 7, 2024
| High |
0.00 | 0.00 |
Tenax Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tenax Therapeutics December 7, 2024 Market Strength
Market strength indicators help investors to evaluate how Tenax Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tenax Therapeutics shares will generate the highest return on investment. By undertsting and applying Tenax Therapeutics stock market strength indicators, traders can identify Tenax Therapeutics entry and exit signals to maximize returns
Tenax Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tenax Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tenax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tenax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1579 | |||
Jensen Alpha | 0.59 | |||
Total Risk Alpha | 0.0823 | |||
Sortino Ratio | 0.1962 | |||
Treynor Ratio | 0.775 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.